Variability of QT Interval Measurements in Opioid‐Dependent Patients on Methadone

Background: Methadone can prolong the QT interval, a precursor to ventricular dysrhythmias. Measurement of the QT interval can vary with intrinsic and extrinsic factors. Our objective was to assess the agreement and repeatability between different QT interval measurements. Methods: We recorded ECGs daily for five consecutive days from adults receiving a stable, single daily dose of methadone for opioid dependence. We compared manually measured QT intervals and the calculated QTc intervals to automated measurements. Results: We obtained 123 ECGs from 26 patients receiving a mean methadone dose of 71 mg/day (range 5 to 240 mg). The manually measured QT intervals from leads II and V5 were similar and consistent (95% limits of agreement ‐46 to 59 ms), as were the corresponding manual QTc. However, the automated QT reported by the ECG was less consistent (95% limits of agreement ‐85 to 65 ms), especially at higher QT intervals and at methadone doses over 100 mg/day. Only one of the two subjects at greatest risk for torsades de pointes was identified based on the automated QT reading, while six other patients had at least one automated QTc over 480 ms that could not be confirmed on manual measurement. Conclusions: Accurate identification of QT prolongation in methadone patients is difficult because of intrinsic patient variability in QT length and accuracy of automated measurements. When contemplating ECG screening for this population, these challenges are best overcome with manual and serial QT measurements, especially at doses exceeding 100 mg/day, and interpretation using a QT nomogram to determine risk of ventricular dysrhythmia.

[1]  M. Stitzer,et al.  Dose-Response Effects of Methadone in the Treatment of Opioid Dependence , 1993, Annals of Internal Medicine.

[2]  J. Caplehorn,et al.  Retention in methadone maintenance and heroin addicts' risk of death. , 1994, Addiction.

[3]  G. Jensen,et al.  Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen , 2007, Heart.

[4]  R. Woosley,et al.  Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. , 2006, Heart rhythm.

[5]  G. Isbister,et al.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. , 2013, British journal of clinical pharmacology.

[6]  A. Moss,et al.  QT Interval: How to Measure It and What Is “Normal” , 2006, Journal of cardiovascular electrophysiology.

[7]  M. Krantz Heterogeneous Impact of Methadone on the QTc Interval: What Are the Practical Implications? , 2008, Journal of addictive diseases.

[8]  D. Altman,et al.  Agreement Between Methods of Measurement with Multiple Observations Per Individual , 2007, Journal of biopharmaceutical statistics.

[9]  L. Grönbladh,et al.  The Swedish methadone maintenance program: a controlled study. , 1981, Drug and alcohol dependence.

[10]  G K Isbister,et al.  Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. , 2007, QJM : monthly journal of the Association of Physicians.

[11]  M. Ross,et al.  Methadone maintenance and the likelihood of risky needle-sharing. , 1995, The International journal of the addictions.

[12]  R. Newman,et al.  DOUBLE-BLIND COMPARISON OF METHADONE AND PLACEBO MAINTENANCE TREATMENTS OF NARCOTIC ADDICTS IN HONG KONG , 1979, The Lancet.

[13]  E. Caine,et al.  Methadone treatment of randomly selected criminal addicts. , 1969, The New England journal of medicine.

[14]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[15]  Peter W Macfarlane,et al.  A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. , 2004, Journal of electrocardiology.

[16]  T. Clausen,et al.  Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. , 2009, Addiction.

[17]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[18]  P. Psaltis,et al.  Electrocardiogram Characteristics of Methadone and Buprenorphine Maintained Subjects , 2008, Journal of addictive diseases.

[19]  Arthur A M Wilde,et al.  Accurate electrocardiographic assessment of the QT interval: teach the tangent. , 2008, Heart rhythm.

[20]  H. Joseph,et al.  LONG‐TERM OUTCOME OF PATIENTS TREATED WITH METHADONE MAINTENANCE * , 1978, Annals of the New York Academy of Sciences.

[21]  D. D. Des Jarlais,et al.  Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review , 1994 .

[22]  A. Pastor,et al.  Prevalence of long QTc interval in methadone maintenance patients. , 2009, Drug and alcohol dependence.

[23]  Bridget A. Martell,et al.  Impact of methadone treatment on cardiac repolarization and conduction in opioid users. , 2005, The American journal of cardiology.

[24]  G. Dunteman,et al.  Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. , 1993, The American journal of drug and alcohol abuse.

[25]  G. Bigelow,et al.  QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. , 2007, Archives of internal medicine.

[26]  Snehal Kothari,et al.  Z‐Score for Benchmarking Reader Competence in a Central ECG Laboratory , 2009, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[27]  Marek Malik,et al.  Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation. , 2004, Journal of electrocardiology.

[28]  I. Maremmani,et al.  QTc interval screening for cardiac risk in methadone treatment of opioid dependence. , 2013, The Cochrane database of systematic reviews.

[29]  G. Jensen,et al.  Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. , 2009, British journal of clinical pharmacology.

[30]  S. Friedman,et al.  Reducing the risk of AIDS through methadone maintenance treatment. , 1988, Journal of health and social behavior.

[31]  P. Friedmann,et al.  Does retention matter? Treatment duration and improvement in drug use. , 2003, Addiction.